| Retinoic acid and arsenic trioxide for acute promyelocytic leukemia F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ... New England Journal of Medicine 369 (2), 111-121, 2013 | 1660* | 2013 |
| Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura M Scully, SR Cataland, F Peyvandi, P Coppo, P Knöbl, ... New England Journal of Medicine 380 (4), 335-346, 2019 | 761 | 2019 |
| Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia R Foa, A Vitale, M Vignetti, G Meloni, A Guarini, MS De Propris, L Elia, ... Blood, The Journal of the American Society of Hematology 118 (25), 6521-6528, 2011 | 490 | 2011 |
| Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study L Annino, ML Vegna, A Camera, G Specchia, G Visani, G Fioritoni, ... Blood, The Journal of the American Society of Hematology 99 (3), 863-871, 2002 | 464 | 2002 |
| Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial JE Cortes, S Khaled, G Martinelli, AE Perl, S Ganguly, N Russell, ... The Lancet Oncology 20 (7), 984-997, 2019 | 429 | 2019 |
| The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells PG Longo, L Laurenti, S Gobessi, S Sica, G Leone, DG Efremov Blood, The Journal of the American Society of Hematology 111 (2), 846-855, 2008 | 375 | 2008 |
| Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase–producing K. pneumoniae M Tumbarello, EM Trecarichi, A Corona, FG De Rosa, M Bassetti, ... Clinical Infectious Diseases 68 (3), 355-364, 2019 | 342 | 2019 |
| Dasatinib–blinatumomab for Ph-positive acute lymphoblastic leukemia in adults R Foà, R Bassan, A Vitale, L Elia, A Piciocchi, MC Puzzolo, M Canichella, ... New England Journal of Medicine 383 (17), 1613-1623, 2020 | 334 | 2020 |
| Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells A Petlickovski, L Laurenti, X Li, S Marietti, P Chiusolo, S Sica, G Leone, ... Blood 105 (12), 4820-4827, 2005 | 331 | 2005 |
| Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population F Efficace, M Baccarani, M Breccia, G Alimena, G Rosti, F Cottone, ... Blood, The Journal of the American Society of Hematology 118 (17), 4554-4560, 2011 | 304 | 2011 |
| The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment V De Stefano, F Sora, E Rossi, P Chiusolo, L Laurenti, L Fianchi, G Zini, ... Journal of Thrombosis and Haemostasis 3 (9), 1985-1992, 2005 | 276 | 2005 |
| Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders V De Stefano, A Fiorini, E Rossi, T Za, G Farina, P Chiusolo, S Sica, ... Journal of Thrombosis and Haemostasis 5 (4), 708-714, 2007 | 262 | 2007 |
| Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation MG Della Porta, A Gallì, A Bacigalupo, S Zibellini, M Bernardi, E Rizzo, ... Journal of clinical oncology 34 (30), 3627, 2016 | 253 | 2016 |
| Response to rituximab-based therapy and risk factor analysis in Epstein Barr virus–related lymphoproliferative disorder after hematopoietic stem cell transplant in children and … J Styczynski, L Gil, G Tridello, P Ljungman, JP Donnelly, ... Clinical infectious diseases 57 (6), 794-802, 2013 | 250 | 2013 |
| Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells S Gobessi, L Laurenti, PG Longo, L Carsetti, V Berno, S Sica, G Leone, ... Leukemia 23 (4), 686-697, 2009 | 248 | 2009 |
| Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups A Bacigalupo, G Socié, H Schrezenmeier, A Tichelli, A Locasciulli, ... haematologica 97 (8), 1142, 2012 | 240* | 2012 |
| ZAP-70 enhances B-cell–receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells S Gobessi, L Laurenti, PG Longo, S Sica, G Leone, DG Efremov Blood 109 (5), 2032-2039, 2007 | 230 | 2007 |
| Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day+ 5 responders and no advantage for nonresponders receiving anti–thymocyte … MT Van Lint, G Milone, S Leotta, C Uderzo, R Scime, S Dallorso, ... Blood 107 (10), 4177-4181, 2006 | 217 | 2006 |
| Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate P Chiusolo, G Reddiconto, I Casorelli, L Laurenti, F Sora, L Mele, ... Annals of oncology 13 (12), 1915-1918, 2002 | 210 | 2002 |
| Treatment of refractory chronic GVHD with rituximab: a GITMO study F Zaja, A Bacigalupo, F Patriarca, M Stanzani, MT Van Lint, C Fili, ... Bone marrow transplantation 40 (3), 273-277, 2007 | 204 | 2007 |
